Home	Fast Track My Amedeo FAQ About	Flying Publisher
Fast Track	FPG #8: Alternative Treatments in Psychiatry FPG #7: Critical Care in Neurology	Free Medical Books

Breast Cancer

Free Subscription Articles published in Oncol Rep Retrieve available abstracts of 39 articles: HTML format Text format

Single Articles

January 2012
1. ZHENG SR , Guo GL, Zhang W, Huang GL, et al
   Clinical significance of miR-155 expression in breast cancer and effects of miR-155 ASO on cell viability and apoptosis.
   Oncol Rep. 2012 Jan 12. doi: 10.3892/or.2012.1634.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
2. PECTASIDES D , Papaxoinis G, Kotoula V, Fountzilas H, et al
   Expression of angiogenic markers in the peripheral blood of docetaxel-treated advanced breast cancer patients: A Hellenic Cooperative Oncology Group (HeCOG) study.
   Oncol Rep. 2012;27:216-24.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   December 2011
3. ZHANG ZJ , Ma SL
   miRNAs in breast cancer tumorigenesis (Review).
   Oncol Rep. 2011 Dec 23. doi: 10.3892/or.2011.1611.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
4. GONZALEZ-VILLASANA V , Nieves-Alicea R, McMurtry V, Gutierrez-Puente Y, et al
   Programmed cell death 4 inhibits leptin-induced breast cancer cell invasion.
   Oncol Rep. 2011 Dec 21. doi: 10.3892/or.2011.1600.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
5. SHENG XJ , Zhou YQ, Song QY, Zhou DM, et al
   Loss of breast cancer metastasis suppressor 1 promotes ovarian cancer cell metastasis by increasing chemokine receptor 4 expression.
   Oncol Rep. 2011 Dec 19. doi: 10.3892/or.2011.1596.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
6. KNUTSON AK , Welsh J, Taylor T, Roy S, et al
   Comparative effects of histone deacetylase inhibitors on p53 target gene expression, cell cycle and apoptosis in MCF-7 breast cancer cells.
   Oncol Rep. 2011 Dec 12. doi: 10.3892/or.2011.1590.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
7. TSERGA A , Michalopoulos NV, Levidou G, Korkolopoulou P, et al
   Association of aberrant DNA methylation with clinicopathological features in breast cancer.
   Oncol Rep. 2011 Dec 5. doi: 10.3892/or.2011.1576.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   November 2011
8. TRINH XB , Sas L, Van Laere SJ, Prove A, et al
   A phase II study of the combination of endocrine treatment and bortezomib in patients with endocrine-resistant metastatic breast cancerA phase II study of the combination of endocrine treatment and bortezomib in patients with endocrine-resistant metas
   Oncol Rep. 2011 Nov 24. doi: 10.3892/or.2011.1562.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
9. LIU CM , Lee WC, Yu CY, Lan KL, et al
   Comparison of the therapeutic efficacy of 188Rhenium-liposomes and liposomal doxorubicin in a 4T1 murine orthotopic breast cancer model.
   Oncol Rep. 2011 Nov 22. doi: 10.3892/or.2011.1557.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
10. ONISHI I , Lin PJ, Numata Y, Austin P, et al
    Organellar (Na+, K+)/H+ exchanger NHE7 regulates cell adhesion, invasion and anchorage-independent growth of breast cancer MDA-MB-231 cells.
    Oncol Rep. 2011 Nov 9. doi: 10.3892/or.2011.1542.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
11. KATAOKA M , Yamaguchi Y, Moriya Y, Sawada N, et al
    Antitumor activity of chemoendocrine therapy in premenopausal and postmenopausal models with human breast cancer xenografts.
    Oncol Rep. 2011 Nov 9. doi: 10.3892/or.2011.1541.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
12. MOLINARI C , Medri L, Follo MY, Piazzi M, et al
    PI-PLCbeta1 gene copy number alterations in breast cancer.
    Oncol Rep. 2011 Nov 8. doi: 10.3892/or.2011.1529.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    October 2011
13. SILVA SN , Guerreiro D, Gomes M, Azevedo AP, et al
    SNPs/Pools: A methodology for the identification of relevant SNPs in breast cancer epidemiology.
    Oncol Rep. 2011 Oct 24. doi: 10.3892/or.2011.1523.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
14. HAN J , Kim S, Yang JH, Nam SJ, et al
    TPA-induced p21 expression augments G2/M arrest through a p53-independent mechanism in human breast cancer cells.
    Oncol Rep. 2011 Oct 20. doi: 10.3892/or.2011.1511.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
15. KIM ES , Jeong CS, Moon A
    Genipin, a constituent of Gardenia jasminoides Ellis, induces apoptosis and inhibits invasion in MDA-MB-231 breast cancer cells.
    Oncol Rep. 2011 Oct 20. doi: 10.3892/or.2011.1508.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
16. RHODES LV , Nitschke AM, Segar HC, Martin EC, et al
    The histone deacetylase inhibitor trichostatin A alters microRNA expression profiles in apoptosis-resistant breast cancer cells.
    Oncol Rep. 2011 Oct 4. doi: 10.3892/or.2011.1488.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    September 2011
17. KIM S , Han J, Kim NY, Lee SK, et al
    Effect of berberine on p53 expression by TPA in breast cancer cells.
    Oncol Rep. 2011 Sep 29. doi: 10.3892/or.2011.1480.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
18. BERNARDI MA , Logullo AF, Pasini FS, Nonogaki S, et al
    Prognostic significance of CD24 and claudin-7 immunoexpression in ductal invasive breast cancer.
    Oncol Rep. 2011 Sep 28. doi: 10.3892/or.2011.1477.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    August 2011
19. BOHM D , Keller K, Wehrwein N, Lebrecht A, et al
    Serum proteome profiling of primary breast cancer indicates a specific biomarker profile.
    Oncol Rep. 2011 Aug 11. doi: 10.3892/or.2011.1420.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
20. GERLOFF A , Dittmer A, Oerlecke I, Holzhausen HJ, et al
    Protein expression of the Ets transcription factor Elf-1 in breast cancer cells is negatively correlated with histological grading, but not with clinical outcome.
    Oncol Rep. 2011 Aug 2. doi: 10.3892/or.2011.1409.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    July 2011
21. TAN BJ , Tan BH, Chiu GN
    Effect of triptolide on focal adhesion kinase and survival in MCF-7 breast cancer cells.
    Oncol Rep. 2011 Jul 28. doi: 10.3892/or.2011.1406.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
22. WANG J , Fu L, Gu F, Ma Y, et al
    Notch1 is involved in migration and invasion of human breast cancer cells.
    Oncol Rep. 2011 Jul 22. doi: 10.3892/or.2011.1399.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
23. STICKELER E , Pils D, Klar M, Orlowsk-Volk M, et al
    Basal-like molecular subtype and HER4 up-regulation and response to neoadjuvant chemotherapy in breast cancer.
    Oncol Rep. 2011 Jul 15. doi: 10.3892/or.2011.1392.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
24. YU B , Zhang Y, Zhan Y, Zha X, et al
    Co-expression of herpes simplex virus thymidine kinase and Escherichia coli nitroreductase by an hTERT-driven adenovirus vector in breast cancer cells results in additive anti-tumor effects.
    Oncol Rep. 2011;26:255-64.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    June 2011
25. TANG ZN , Zhang F, Tang P, Qi XW, et al
    RANKL-induced migration of MDA-MB-231 human breast cancer cells via Src and MAPK activation.
    Oncol Rep. 2011 Jun 30. doi: 10.3892/or.2011.1368.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
26. ZHANG W , Wang L, Fan Q, Wu X, et al
    Arsenic trioxide re-sensitizes ERalpha-negative breast cancer cells to endocrine therapy by restoring ERalpha expression in vitro and in vivo.
    Oncol Rep. 2011 Jun 17. doi: 10.3892/or.2011.1352.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    May 2011
27. KANEMATSU S , Yoshizawa K, Uehara N, Miki H, et al
    Sulforaphane inhibits the growth of KPL-1 human breast cancer cells in vitro and suppresses the growth and metastasis of orthotopically transplanted KPL-1 cells in female athymic mice.
    Oncol Rep. 2011 May 20. doi: 10.3892/or.2011.1311.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
28. PUPPIN C , Puglisi F, Pandolfi M, Di Loreto C, et al
    Histone deacetylase inhibitors induce thymidine phosphorylase expression in cultured breast cancer cell lines.
    Oncol Rep. 2011 May 20. doi: 10.3892/or.2011.1310.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
29. CERNE JZ , Novakovic S, Frkovic-Grazio S, Pohar-Perme M, et al
    Estrogen metabolism genotypes, use of long-term hormone replacement therapy and risk of postmenopausal breast cancer.
    Oncol Rep. 2011 May 10. doi: 10.3892/or.2011.1298.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
30. GUO Z , He Y, Wang S, Zhang A, et al
    Various effects of hepatoma-derived growth factor on cell growth, migration and invasion of breast cancer and prostate cancer cells.
    Oncol Rep. 2011 May 4. doi: 10.3892/or.2011.1295.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    April 2011
31. YUAN Z , Sanders AJ, Ye L, Wang Y, et al
    Knockdown of human antigen R reduces the growth and invasion of breast cancer cells in vitro and affects expression of cyclin D1 and MMP-9.
    Oncol Rep. 2011 Apr 18. doi: 10.3892/or.2011.1271.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
32. THONGWATCHARA P , Promwikorn W, Srisomsap C, Chokchaichamnankit D, et al
    Differential protein expression in primary breast cancer and matched axillary node metastasis.
    Oncol Rep. 2011 Apr 15. doi: 10.3892/or.2011.1266.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
33. LEU JD , Wang CY, Tsai HY, Lin IF, et al
    Involvement of p53 R72P polymorphism in the association of MDM2-SNP309 with breast cancer.
    Oncol Rep. 2011 Apr 8. doi: 10.3892/or.2011.1254.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
34. SHI Y , Yang S, Troup S, Lu X, et al
    Resveratrol induces apoptosis in breast cancer cells by E2F1-mediated up-regulation of ASPP1.
    Oncol Rep. 2011 Apr 6. doi: 10.3892/or.2011.1248.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    March 2011
35. PARK SY , Jun JA, Jeong KJ, Heo HJ, et al
    Histone deacetylases 1, 6 and 8 are critical for invasion in breast cancer.
    Oncol Rep. 2011 Mar 28. doi: 10.3892/or.2011.1236.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
36. SANTINI D , Vincenzi B, Adamo V, Addeo R, et al
    Cigarette smoking habit does not reduce the benefit from first line trastuzumab-based treatment in advanced breast cancer patients.
    Oncol Rep. 2011 Mar 28. doi: 10.3892/or.2011.1235.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    February 2011
37. CUI H , Lin Y, Yue L, Zhao X, et al
    Differential expression of the alpha2,3-sialic acid residues in breast cancer is associated with metastatic potential.
    Oncol Rep. 2011 Feb 22. doi: 10.3892/or.2011.1192.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
38. NOGI H , Suzuki M, Kamio M, Kato K, et al
    Impact of CD44+CD24- cells on non-sentinel axillary lymph node metastases in sentinel node-positive breast cancer.
    Oncol Rep. 2011 Feb 9. doi: 10.3892/or.2011.1177.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    January 2011
39. KWON Y , Ro J, Kang HS, Kim SK, et al
    Clinicopathological parameters and biological markers predicting non-sentinel node metastasis in sentinel node-positive breast cancer patients.
    Oncol Rep. 2011 Jan 21. doi: 10.3892/or.2011.1157.
    PubMed     Text format     Related articles    Abstract available
    
    
    

Thank you for your interest in scientific medicine.

Amedeo is a Flying Publisher website.    Design: